These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31277703)

  • 1. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model.
    Rossaert E; Pollari E; Jaspers T; Van Helleputte L; Jarpe M; Van Damme P; De Bock K; Moisse M; Van Den Bosch L
    Acta Neuropathol Commun; 2019 Jul; 7(1):107. PubMed ID: 31277703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Burg T; Rossaert E; Moisse M; Van Damme P; Van Den Bosch L
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A Relieves Growth Suppression and Restores Histone Acetylation at Specific Sites in a FUS ALS/FTD Yeast Model.
    Bennett SA; Cobos SN; Mirzakandova M; Fallah M; Son E; Angelakakis G; Rana N; Hugais M; Torrente MP
    Biochemistry; 2021 Dec; 60(48):3671-3675. PubMed ID: 34788013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS.
    Arenas A; Chen J; Kuang L; Barnett KR; Kasarskis EJ; Gal J; Zhu H
    Hum Mol Genet; 2020 Sep; 29(16):2684-2697. PubMed ID: 32691043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of cognitive deficits in FUS
    Pelaez MC; Fiore F; Larochelle N; Dabbaghizadeh A; Comaduran MF; Arbour D; Minotti S; Marcadet L; Semaan M; Robitaille R; Nalbantoglu JN; Sephton CF; Durham HD
    Neurotherapeutics; 2024 Sep; 21(5):e00388. PubMed ID: 38972779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
    Yoo YE; Ko CP
    Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
    Ganai SA; Banday S; Farooq Z; Altaf M
    Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1.
    Tibshirani M; Tradewell ML; Mattina KR; Minotti S; Yang W; Zhou H; Strong MJ; Hayward LJ; Durham HD
    Hum Mol Genet; 2015 Feb; 24(3):773-86. PubMed ID: 25274782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting histone deacetylases: development of vorinostat for the treatment of cancer.
    Richon VM
    Epigenomics; 2010 Jun; 2(3):457-65. PubMed ID: 22121904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of histone deacetylase inhibition and arimoclomol on heat shock protein expression and disease biomarkers in primary culture models of familial ALS.
    Fernández Comaduran M; Minotti S; Jacob-Tomas S; Rizwan J; Larochelle N; Robitaille R; Sephton CF; Vera M; Nalbantoglu JN; Durham HD
    Cell Stress Chaperones; 2024 Jun; 29(3):359-380. PubMed ID: 38570009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
    Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
    Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models.
    Kuta R; Larochelle N; Fernandez M; Pal A; Minotti S; Tibshirani M; St Louis K; Gentil BJ; Nalbantoglu JN; Hermann A; Durham HD
    Cell Stress Chaperones; 2020 Jan; 25(1):173-191. PubMed ID: 31900865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Level of Expression of C-Terminally Truncated Human FUS Causes Extensive Changes in the Spinal Cord Transcriptome of Asymptomatic Transgenic Mice.
    Lysikova EA; Funikov S; Rezvykh AP; Chaprov KD; Kukharsky MS; Ustyugov A; Deykin AV; Flyamer IM; Boyle S; Bachurin SO; Ninkina N; Buchman VL
    Neurochem Res; 2020 May; 45(5):1168-1179. PubMed ID: 32157564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.
    Guo W; Naujock M; Fumagalli L; Vandoorne T; Baatsen P; Boon R; Ordovás L; Patel A; Welters M; Vanwelden T; Geens N; Tricot T; Benoy V; Steyaert J; Lefebvre-Omar C; Boesmans W; Jarpe M; Sterneckert J; Wegner F; Petri S; Bohl D; Vanden Berghe P; Robberecht W; Van Damme P; Verfaillie C; Van Den Bosch L
    Nat Commun; 2017 Oct; 8(1):861. PubMed ID: 29021520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice.
    Bankole O; Scambi I; Parrella E; Muccilli M; Bonafede R; Turano E; Pizzi M; Mariotti R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice.
    Buonvicino D; Felici R; Ranieri G; Caramelli R; Lapucci A; Cavone L; Muzzi M; Di Pietro L; Bernardini C; Zwergel C; Valente S; Mai A; Chiarugi A
    Neuroscience; 2018 May; 379():228-238. PubMed ID: 29588251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.
    Bennett SA; Tanaz R; Cobos SN; Torrente MP
    Transl Res; 2019 Feb; 204():19-30. PubMed ID: 30391475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
    Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
    Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy.
    Funikov SY; Rezvykh AP; Mazin PV; Morozov AV; Maltsev AV; Chicheva MM; Vikhareva EA; Evgen'ev MB; Ustyugov AA
    Neurogenetics; 2018 Aug; 19(3):189-204. PubMed ID: 29982879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.